New: Levo reduced-ligature recliner

Designed to minimise ligature risks

Patients living with mental health disorders also experience higher frequencies of physical illnesses including cardiovascular¹, respiratory² and metabolic³ disorders.

These comorbidities can result in patients with complex mobility needs who can benefit from the restful and repositionable nature of a reclining chair.

There are also situations, for example during crisis stabilisation, during which short periods of rest and sleep may be required until an assessment has been made.

Many reclining chairs can present safety risks in mental health environments, either due to their controls (handles, buttons and electric handsets) or their reclining mechanisms, which may be tampered with or used as a ligature point.

The Levo reduced-ligature reclining chair has been designed to minimise these risks. Activated by body weight alone, there are no external controls, and the reclining mechanism has been made inaccessible to minimise ligature risks.

Ease of cleaning

Levo’s modular construction allows staff to separate the seat from the base to enable thorough cleaning and safer inspection practices. The modular design also means sections can be repaired individually, extending the life of the furniture and minimising waste.

Key features
  • Reclining motion is controlled with body weight – no controls or power required
  • Inaccessible internal mechanism designed to minimise ligature risks
  • The generous width seat provides comfort during long periods of sitting and sleeping
  • The high-back design offers head and neck support
  • Robust and hygienic polyethylene base
  • Base is made from 100% recyclable materials
Options
  • Available with additional weighting (134kg)
  • Seat and back available in a wide range of water-resistant upholstery
  • Arms and base available in 13 versatile colours

Click to explore Levo reduced-ligature recliner.

Download the brochure here.


References

1. Nielsen RE, Banner J, Jensen SE. Cardiovascular disease in patients with severe mental illness. Nat Rev Cardiol. 2021;18(2):136–145

2. Brown S, Kim M, Mitchell C, Inskip H: Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry 2010;196:116-121

3. Wysokinski A, Strzelecki D, Kloszewska I. Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder. Diabetes Metab Syndr. 2015;9:168–176

FIND OUT WHAT ELSE WE HAVE BEEN UP TO

Read more

Our global network of offices and partners means we're on-hand to help, wherever help is needed.

X
Mainland Europe
Scandinavia
North America
Middle East
Australasia
Africa